Sirion Holdings
Founded Year
2005Stage
Debt | AliveTotal Raised
$47.5MLast Raised
$2.5M | 14 yrs agoMissing: Sirion Holdings's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Sirion Holdings's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Sirion Holdings
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Sirion Holdings is included in 1 Expert Collection, including Biopharma Tech.
Biopharma Tech
5,241 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Sirion Holdings Frequently Asked Questions (FAQ)
When was Sirion Holdings founded?
Sirion Holdings was founded in 2005.
Where is Sirion Holdings's headquarters?
Sirion Holdings's headquarters is located at 3110 Cherry Palm Drive, Tampa.
What is Sirion Holdings's latest funding round?
Sirion Holdings's latest funding round is Debt.
How much did Sirion Holdings raise?
Sirion Holdings raised a total of $47.5M.
Who are the investors of Sirion Holdings?
Investors of Sirion Holdings include Aisling Capital, Tullis Health Investors, Advent International, North Sound Capital, QHP Capital and 8 more.
Who are Sirion Holdings's competitors?
Competitors of Sirion Holdings include Ikaria, Revance Therapeutics, Evoke Pharma, Omthera Pharmaceuticals, SkinMedica and 13 more.
Compare Sirion Holdings to Competitors
Tequesta Marine Biosciences is a specialty pharmaceutical firm that develops small molecule therepeutic drugs for inflammatory conditions.
Axcan is a specialty pharmaceutical company focused on the development and commercialization of drugs for diseases involving the digestive system.
QOL Medical is a specialty pharmaceutical company focused on the gastrointestinal market.
Charleston Laboratories, Inc is a specialty pharmaceutical company focused on the research and development of pain products that prevent or significantly reduce nausea and vomiting, the two most burdensome side effects related to opioid analgesics and other pain associated disease states.
Ameritox is the nation's leader in pain prescription monitoring.
Urigen specializes in the design and commercialization of innovative products for patients with urological ailments. The company develops products for amelioration of Painful Bladder Syndrome (PBS), Urethritis, Nocturia and Over Active Bladder (OAB).
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.